Form 4: Cosmos Health CEO Converts Debt to Equity

Sentiment:

Insider Transaction Report


Cosmos Health Inc. CEO Grigorios Siokas acquired 76,360 shares of common stock by converting $49,000 of company debt into equity at $0.6417 per share.

Capital raiseCosmos Health Inc. engaged in a debt-to-equity conversion with its CEO, Grigorios Siokas, effectively converting $49,000 of company debt into 76,360 shares of common stock.This transaction serves as a form of capital restructuring, reducing the company's liabilities and altering its capital composition.

Summary

  • Grigorios Siokas, the Chief Executive Officer, Director, and 10% Owner of Cosmos Health Inc. (COSM), acquired 76,360 shares of the company's common stock.
  • The transaction occurred on November 28, 2025, with a deemed execution date on the same day.
  • The shares were acquired at an exchange rate of $0.6417 per share, which was the fair market value of the common stock on November 28, 2025.
  • This acquisition was made pursuant to a debt exchange agreement dated December 1, 2025, between Mr. Siokas and the company.
  • Mr. Siokas converted a total of $49,000 in debt that the company owed to him into equity.
  • Following this transaction, Mr. Siokas beneficially owns 6,459,985 shares of Cosmos Health Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the debt reduction and insider confidence are favorable, the need for a debt-to-equity conversion and the resulting dilution introduce a degree of neutrality.

Positives

  • The company reduced its outstanding debt by $49,000, strengthening its balance sheet.
  • The conversion of debt to equity by the CEO demonstrates confidence in the company's future prospects and aligns management's interests with shareholders.
  • The transaction avoids a cash outflow for debt repayment, preserving the company's liquidity.

Negatives

  • Existing shareholders experienced minor dilution due to the issuance of new shares as part of the debt-to-equity conversion.

Risks

  • The necessity for a debt-to-equity conversion could signal underlying financial strain or liquidity challenges for the company.
  • Potential for further debt-to-equity conversions in the future if the company continues to face financial pressures, leading to additional shareholder dilution.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

  • The shares acquired by Mr. Siokas are 'Exchange Shares' pursuant to a debt exchange agreement, being acquired at an 'Exchange Rate' of $0.6417 per share, which was the fair market value of the Common Stock on November 28, 2025, in exchange for $49,000 in debt the Company owed to Mr. Siokas.

Industry Context

Debt-to-equity conversions are a common financial strategy employed by companies to reduce their liabilities and improve their balance sheet, particularly when managing cash flow or seeking to strengthen capital structure. Such transactions, especially when involving insiders, can signal management's commitment and belief in the company's long-term value, while also resulting in dilution for existing shareholders.

Related Party Transactions

  • Grigorios Siokas, who serves as the Chief Executive Officer, Director, and a 10% owner of Cosmos Health Inc., entered into a debt exchange agreement with the company.
  • Under this agreement, $49,000 of debt owed by the company to Mr. Siokas was converted into 76,360 shares of common stock.

Stakeholder Impact

  • Shareholders: Experience minor dilution from the issuance of new shares, but benefit from the company's reduced debt load.
  • Creditors (specifically Grigorios Siokas): His status as a creditor for $49,000 was converted into an equity stake, aligning his financial interests more directly with the company's performance.
  • Company: Benefits from a stronger balance sheet due to debt reduction and avoids a cash expenditure for debt repayment.

Key Dates

DateDescription
11/28/2025Transaction Date and Deemed Execution Date for the acquisition of common stock by Grigorios Siokas.
12/01/2025Date of the Debt Exchange Agreement between Grigorios Siokas and Cosmos Health Inc., and the signature date of the Form 4 filing.

Keywords

Cosmos Health Inc., COSM, Grigorios Siokas, Form 4, insider transaction, debt exchange, equity conversion, CEO, beneficial ownership, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.